Arcellx

Scroll
Investment area
Novo Ventures
Region
Eastern USA
Date of investment
September 2017

Immuno-oncology company developing CAR T-Cell Therapy for treatment of Cancer.

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more